Evidence map›Paper›PMID 33537088›Full record

ArticleTheranostics2021

RGD-expressed bacterial membrane-derived nanovesicles enhance cancer therapy

Jin Gao, Sihan Wang, Xinyue Dong, Zhenjia Wang

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Frontiers in immunology · 2026
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Roles of naïve CD4Journal of translational medicine · 2024
    Article
  13. Bacteria-Based Nanoprobes for Cancer Therapy.International journal of nanomedicine · 2024
    Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Bacterial-Mediated Tumor Therapy: Old Treatment in a New Context.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jin GaoDepartment of Pharmaceutical Sciences, College of Pharmaceutical Sciences and Pharmacy, Washington State University, Spokane, WA 99202, USA.
Sihan WangDepartment of Pharmaceutical Sciences, College of Pharmaceutical Sciences and Pharmacy, Washington State University, Spokane, WA 99202, USA.
Xinyue DongDepartment of Pharmaceutical Sciences, College of Pharmaceutical Sciences and Pharmacy, Washington State University, Spokane, WA 99202, USA.
Zhenjia WangDepartment of Pharmaceutical Sciences, College of Pharmaceutical Sciences and Pharmacy, Washington State University, Spokane, WA 99202, USA.
Washington State University Spokane · US

Funding

Active Drug Loading to Nanovesicles for Targeted Drug DeliveryR01EB027078 · NIBIB · WASHINGTON STATE UNIVERSITY · PI WANG, ZHENJIA · 2019 to 2023
$1.4M
NIBIB NIH HHS R01 EB027078
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntibiotics, AntineoplasticCell MembraneDoxorubicinDrug CompoundingDrug Delivery SystemsEscherichia coliGene ExpressionGenes, ReporterGreen Fluorescent ProteinsIntegrin alphaVbeta3MaleMelanoma, ExperimentalMiceMice, Inbred C57BLMonocytesAntibiotics, Antineoplasticarginyl-glycyl-aspartic acidDoxorubicinenhanced green fluorescent proteinGreen Fluorescent ProteinsIntegrin alphaVbeta3OligopeptidesRecombinant Fusion ProteinsBacterial membrane-derived nanovesiclesDoxorubicinInflammation response.Remote loadingTumor microenvironments

Identifiers

PMID33537088
PMCPMC7847689
OpenAlexW3128056022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.